First Long-Term Data on Atogepant for Migraine Prevention First Long-Term Data on Atogepant for Migraine Prevention

Interim data from an ongoing open-label extension study support the long-term safety and efficacy of atogepant for prevention of chronic and episodic migraine.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news